ReiThera is a CDMO dedicated to technology and process development and viral vector GMP manufacturing. The company developed a highly innovative technological platform based on simian adenoviral vectors applicable for vaccine and advanced therapy applications. ReiThera is actively setting up scalable processes applicable to AAV, LV, MVA, HSV. ReiThera has a state-of-the-art facility with stirred-tank bioreactors (50 - 2000L) including cell lines, filling suite and quality control laboratories.

Brands: ReiThera is open to meet companies interested in exploring the possibility of performing process development and GMP production for clinical trial supply and commercial purposes.